AHLEN, Germany–(BUSINESS WIRE)–The Social Commerce Company LR Health & Beauty is looking back on 40 years of company history this year. The company, which was founded in 1985, has developed into a global player in the direct selling industry in recent years. LR Health & Beauty has been setting innovative trends in the nutritional supplements and cosmetics sector for 40 years. The unique selling point: The products are sold by independent sales partners who earn an additional income by

AHLEN, Deutschland–(BUSINESS WIRE)–Das Social-Commerce-Unternehmen LR Health & Beauty blickt in diesem Jahr auf 40 Jahre Unternehmensgeschichte zurück. Das Unternehmen, das 1985 gegründet wurde, hat sich in den letzten Jahren zum globalen Player in der Direktvertriebsbranche entwickelt. LR Health & Beauty setzt seit 40 Jahren innovative Impulse im Nahrungsergänzungsmittel- und Kosmetikbereich. Das Besondere: Die Produkte werden über selbstständige Vertriebspartner vertrieben, die mit

WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer Health today announced that Lippincott® Ready for NCLEX®-RN will now feature AI-driven remediation with personalized, multi-modal improvement plans, benefiting both nurse educators and students. These innovative, easy-to-use enhancements better prepare students for their nursing licensure exam, the Next Generation National Council Licensure Examination (NCLEX), by providing adaptive and clinically focused learning materials. “Lippincott Nursing Ed

HAYWARD, Calif.–(BUSINESS WIRE)– #CancerTherapy–RefleXion® Medical, an external-beam theranostic oncology company, today announced initiation of the BIOGUIDE-X2 clinical study to expand indications for SCINTIX® biology-guided radiotherapy at Hackensack Meridian John Theurer Cancer Center, a research partner with Georgetown’s Lombardi Comprehensive Cancer Center, an NCI-designated comprehensive cancer center. The company also announced key updates from the Centers for Medicare and Medicaid (CMS) Services. Sta

IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide arr

SAN DIEGO–(BUSINESS WIRE)–Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced the appointment of Cayce Denton as chief financial officer. Ms. Denton brings over two decades of experience in finance, strategy, and business development within the biotech and pharmaceutical industries, most recently serving as general p

CHARLOTTE, N.C.–(BUSINESS WIRE)–Whistle Express Car Wash, a leading brand in the rapidly consolidating car wash industry, today announced its successful fundraising campaign for Children’s Miracle Network Hospitals, a renowned organization dedicated to improving children’s healthcare through community-driven efforts, raising an impressive $34,648 to benefit 27 local children’s hospitals across the Midwest and Southeast. This donation underscores Whistle Express’s commitment to making a positi

BRISBANE, Calif.–(BUSINESS WIRE)– #CRISPR–Mammoth Biosciences announces presentation at the 2025 J.P. Morgan Healthcare Conference

SAN FRANCISCO–(BUSINESS WIRE)–Hinge Health released its fifth annual State of Musculoskeletal (MSK) Care Report, highlighting the strengths of digital care for joint and muscle pain compared to traditional care. With nearly 40% of U.S. adults experiencing MSK conditions that generate estimated annual medical expenses of approximately $381 billion, digital care solutions like Hinge Health can fill in the affordability, awareness, and accessibility gaps, bolstering quality of life and reducing

NEW YORK–(BUSINESS WIRE)–Celmatix Therapeutics, a biotechnology company focused on advancing groundbreaking therapeutics for women’s health, has announced its latest drug program, a novel Jun-N-terminal kinase (JNK) inhibitor that targets pain and inflammation. The therapeutic drug candidate, developed using the DNA-Encoded Chemistry Technology (DEC-Tec) platform at the Center for Drug Discovery, Baylor College of Medicine (BCM), aims to address a critical unmet need in first-line treatments